New gel treatment for venous leg ulcers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of TR987 0.1% gel combined with Standard of Care compared to Standard of Care alone in treating non-healing Venous Leg Ulcers (VLUs). It is a randomized, double-blind, multicenter study lasting 16 weeks, focusing on the complete closure of the target ulcer. Secondary endpoints include pain level changes and ulcer area reduction over the treatment period. The study aims to provide insights into both the efficacy and safety of the gel treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults 18 years and older
* Venous insufficiency has been clinically diagnosed clinically and medically confirmed.
* Females who are neither pregnant nor breastfeeding and if of child-bearing potential are on an acceptable method of birth control.
* The Venous Ulcer should be between 2 cm2 and 12 cm2 at randomization.
* Target ulcer age must be ≥ 4 weeks at Screening.
* Participants must have adequate arterial flow as confirmed by ABI/TBI, TB, SPP, TCPo2, or Duplex Doppler.
* Body mass index (BMI) ≤ 50 kg/m2.
* HbA1C ≤12%.

Exclusion Criteria:

* Target ulcer has been treated with prohibited medications or therapies.
* History of radiation at the target ulcer site.
* Target ulcer decreases in area by 30% or more during screening period.
* History of osteomyelitis at the target ulcer within 6 months of screening.
* History of cancer in the preceding 5 years (except as noted in the protocol).
* Participants considered nutritionally deficient.

Where it's running

• Clincial Research Site 92
  Jacksonville, Florida, United States Recruiting
• Clincial Research Site 77
  Clinton Twp, Michigan, United States Recruiting
• Clinical Research Site 76
  Fort Worth, Texas, United States Recruiting
• Clincial Research Site 60
  Ivanhoe, Victoria, Australia Recruiting
• Clincial Research Site 65
  Shepparton, Victoria, Australia Recruiting
• Clincial Research Site 82
  Lake Success, New York, United States Not yet recruiting

Study contacts

• Study coordinator: Anhthu Nguyen Vice President, Global Clinical Operations
• Email: anhthu.nguyen@trtherapeutics.com
• Phone: (+61) 280 034 554

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tissue Repair Gel for treating Venous Leg Ulcers

  This study is testing a new gel to see if it helps people with stubborn leg ulcers heal better when used with standard treatment compared to standard treatment alone.

  Recruiting at 24 sites Phase 3 TR Therapeutics · Tucson, Arizona and 32 other locations · NCT06707090

• GORE VIABAHN FORTEGRA Venous Stent Post-Approval Study

  This study tests the GORE VIABAHN FORTEGRA Venous Stent in real-world patients with venous diseases to see how it performs after it is approved.

  Recruiting at 4 sites W.L.Gore & Associates · Darien, Connecticut and 3 other locations · NCT07538609

• Human placental membrane products plus standard care for nonhealing diabetic foot and venous leg ulcers

  This trial will try human placental membrane products together with standard wound care to help adults whose diabetic foot ulcers or venous leg ulcers have not healed.

  Recruiting BioLab Holdings · Philidelphia, Pennsylvania · NCT07364630

• Amnion grafts for hard-to-heal diabetic foot and venous leg ulcers

  This study will test whether two types of amnion grafts, added to standard wound care, help hard-to-heal diabetic foot and venous leg ulcers heal better.

  Recruiting at 7 sites Capsicure, LLC · Oxnard, California and 6 other locations · NCT07046767

• Evaluating how long venous leg ulcers stay closed after treatment

  This study is testing how long venous leg ulcers stay closed after treatment with a special fish skin graft compared to standard care alone.

  Recruiting Kerecis Ltd. · Monroeville, Pennsylvania · NCT06697925

• Using porcine placental matrix to improve healing of venous leg ulcers

  This study is testing if adding a special treatment made from pig placenta to regular care can help heal stubborn leg ulcers that haven't improved with standard treatments.

  Recruiting ConvaTec Inc. · North Port, Florida · NCT06606210

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.